揭开结直肠癌的复杂性:异质性,克隆进化和临床影响
Nadia Saoudi González1,2, Francesc Salvà1,2, Javier Ros1,2
1Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Cancers
|August 26, 2023
概括
结肠直肠癌 (CRC) 的异质性会影响治疗. 分析循环瘤DNA (ctDNA) 有助于监测克隆进化,并预测转移性CRC患者的结果,指导个性化治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 是一个重要的全球健康问题.
- 在原发性和转移性部位内和之间瘤异质性会影响CRC的进展和治疗反应.
- 关键生物标志物如KRAS,NRAS和BRAF突变指导转移性CRC的治疗.
研究的目的:
- 审查患者内癌症异质性和转移性结直肠癌中的遗传克隆进化.
- 强调理解瘤异质性的临床应用.
- 突出循环瘤DNA (ctDNA) 在监测治疗反应中的作用.
主要方法:
- 使用下一代测序进行全面的基因组研究.
- 计算分析以了解克隆进化.
- 液体活检用于ctDNA分析,以监测实时变化.
主要成果:
- 初级和转移性CRC病变之间的突变状态高度一致,但存在一些异质性.
- ctDNA分析对于识别遗传异质性和预测RAS突变转移性CRC的预后是有价值的.
- 液体活检可以实时监测克隆进化和治疗反应.
结论:
- 了解瘤异质性对于有效的结直肠癌管理至关重要.
- ctDNA分析提供了一种非侵入性的方法来追踪瘤的进化,并指导治疗策略.
- 为了准确地描述瘤亚群和改善临床效用,需要进一步的标准化.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383


